Doctor profile · Federal record
Dr. RYAN LINGLE, DO
Family Medicine Physician (CMS: FAMILY PRACTICE) · Student in an Organized Health Care Education/Training Program · LA PORTE, IN
- NPI 1891290631
- Accepts Medicare
- 8 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
900 I ST
LA PORTE, IN 463505533
(219) 324-1700
fax (219) 324-1602 - Mailing address
-
3245 HEALTH DR STE 100
GRANGER, IN 465301380
Credentials & registration
- NPI registered
- March 2018 — 8 yrs on file
- Profile last updated
- April 28, 2023
- Year of graduation
- 2018 — 8 yrs since
- Specialty taxonomy
- 207Q00000X — NUCC code
- State license (1)
- Indiana #02006279
- Medicaid
- IN #300050152
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1891290631. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,576
Distinct HCPCS
7
Medicare allowed
$113,270
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
36415 |
Insertion of needle into vein for collection of blood sample | 476 | 255 | $8 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 407 | 252 | $118 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 263 | 177 | $83 | |
G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 222 | 222 | $120 | |
G0008 |
Administration of influenza virus vaccine | 94 | 94 | $29 | |
90662 |
Influenza vaccine split virus, preservative free | 91 | 91 | $72 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 23 | 23 | $153 |
In context: peer comparison
Among 6 peers in this city , average services per provider: 679. This provider delivers 2.3× the peer median.Open Payments
Industry payments received
All-time total
$824
Transactions
36
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. | 2 | $137.77 | |
| Novo Nordisk Inc | 6 | $115.45 | |
| Lundbeck LLC | 4 | $88.34 | |
| Lilly USA, LLC | 4 | $86.98 | |
| PFIZER INC. | 4 | $67.94 | |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $54.06 | |
| ABBVIE INC. | 2 | $48.45 | |
| Mylan Specialty L.P. | 2 | $47.71 | |
| Otsuka America Pharmaceutical, Inc. | 2 | $34.38 | |
| Novartis Pharmaceuticals Corporation | 2 | $28.32 | |
| Sumitomo Pharma America, Inc. | 1 | $22.61 | |
| Phathom Pharmaceuticals, Inc. | 1 | $18.71 | |
| Astellas Pharma US Inc | 1 | $16.72 | |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14.66 | |
| GlaxoSmithKline, LLC. | 1 | $14.40 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,211
Patients
739
Total drug cost
$106,512
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Atorvastatin Calcium | Generic | 373 | 126 | $3,735 |
| Lisinopril | Generic | 215 | 74 | $1,574 |
| Levothyroxine Sodium | Generic | 190 | 57 | $2,798 |
| Amlodipine Besylate | Generic | 188 | 70 | $1,379 |
| Metformin Hcl | Generic | 166 | 55 | $1,702 |
| Losartan Potassium | Generic | 147 | 58 | $1,654 |
| Alprazolam | Generic | 128 | 30 | $618 |
| Hydrochlorothiazide | Generic | 127 | 44 | $594 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 116 | 34 | $3,239 |
| Pantoprazole Sodium | Generic | 104 | 32 | $1,564 |